M&AHealthcareSIGNED
Cruinn Diagnostics, Backed by Waterland, Acquires Katalyst Diagnostics
Acquirer
Cruinn Diagnostics
Target
Katalyst Diagnostics
Cruinn Diagnostics, a portfolio company of Waterland Private Equity, has acquired Katalyst Diagnostics. This move signifies Cruinn's entry into a new market.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.